Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Haemonetics Scandinavia Aktiebolag
AB
In liquidation
Org 5561970715
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1978
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Haemonetics Scandinavia Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
ME
Martin Erik Sigurd Sjöström
Liquidator
Liquidator
2022
LJ
Lars Johan Peter Gunnarsson
Chief Auditor
Chief Auditor
2020
Former (2)
AC
Alessandro Casanova
Chief Executive Officer
Chief Executive Officer
2020 – 2021
WP
William Patrick Burke
Liquidator
Liquidator
2020 – 2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
HAEMONETICS CORPORATION
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Haemonetics Scandinavia Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot